About this Journal Submit a Manuscript Table of Contents
International Journal of Hypertension
Volume 2013 (2013), Article ID 136028, 8 pages
http://dx.doi.org/10.1155/2013/136028
Review Article

The Brain Renin-Angiotensin System and Mitochondrial Function: Influence on Blood Pressure and Baroreflex in Transgenic Rat Strains

1Hypertension and Vascular Research Center, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1032, USA
2Department of General Surgery, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1032, USA

Received 2 October 2012; Accepted 23 December 2012

Academic Editor: Robert C. Speth

Copyright © 2013 Manisha Nautiyal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. B. Averill and D. I. Diz, “Angiotensin peptides and baroreflex control of sympathetic outflow: pathways and mechanisms of the medulla oblongata,” Brain Research Bulletin, vol. 51, no. 2, pp. 119–128, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. M. J. Campagnole-Santos, S. B. Heringer, E. N. Batista, M. C. Khosla, and R. A. S. Santos, “Differential baroreceptor reflex modulation by centrally infused angiotensin peptides,” American Journal of Physiology, vol. 263, no. 1, part 2, pp. R89–R94, 1992. View at Scopus
  3. D. I. Diz, J. A. Jessup, B. M. Westwood et al., “Angiotensin peptides as neurotransmitters/neuromodulators in the dorsomedial medulla,” Clinical and Experimental Pharmacology and Physiology, vol. 29, no. 5-6, pp. 473–482, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. D. I. Diz, A. C. Arnold, M. Nautiyal, K. Isa, H. A. Shaltout, and E. A. Tallant, “Angiotensin peptides and central autonomic regulation,” Current Opinion in Pharmacology, vol. 11, no. 2, pp. 131–137, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. A. C. Arnold, A. Sakima, D. Ganten, C. M. Ferrario, and D. I. Diz, “Modulation of reflex function by endogenous angiotensins in older transgenic rats with low glial angiotensinogen,” Hypertension, vol. 51, no. 5, pp. 1326–1331, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Sakima, D. B. Averill, P. E. Gallagher et al., “Impaired heart rate baroreflex in older rats: Role of endogenous angiotensin-(1–7) at the nucleus tractus solitarii,” Hypertension, vol. 46, no. 2, pp. 333–340, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. E. M. de Cavanagh, B. Piotrkowski, N. Basso et al., “Enalapril and losartan attenuate mitochondrial dysfunction in aged rats,” The FASEB Journal, vol. 17, no. 9, pp. 1096–1098, 2003. View at Scopus
  8. E. M. V. de Cavanagh, J. E. Toblli, L. Ferder et al., “Angiotensin II blockade improves mitochondrial function in spontaneouslyhypertensive rats,” Cellular and Molecular Biology, vol. 51, no. 6, pp. 573–578, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. E. M. V. de Cavanagh, J. E. Toblli, L. Ferder, B. Piotrkowski, I. Stella, and F. Inserra, “Renal mitochondrial dysfunction in spontaneously hypertensive rats is attenuated by losartan but not by amlodipine,” American Journal of Physiology, vol. 290, no. 6, pp. R1616–R1625, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. E. M. V. de Cavanagh, L. Ferder, J. E. Toblli et al., “Renal mitochondrial impairment is attenuated by AT1 blockade in experimental type I diabetes,” American Journal of Physiology, vol. 294, no. 1, pp. H456–H465, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. I. F. Benter, M. H. M. Yousif, F. M. Al-Saleh, R. Raghupathy, M. C. Chappell, and D. I. Diz, “Angiotensin-(1–7) blockade attenuates captopril- or hydralazine-induced cardiovascular protection in spontaneously hypertensive rats treated with NG-nitro-l-arginine methyl ester,” Journal of Cardiovascular Pharmacology, vol. 57, no. 5, pp. 559–567, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. H. A. Shaltout, J. C. Rose, M. C. Chappell, and D. I. Diz, “Angiotensin-(1–7) deficiency and baroreflex impairment precede the antenatal Betamethasone exposure-induced elevation in blood pressure,” Hypertension, vol. 59, no. 2, pp. 453–458, 2012. View at Publisher · View at Google Scholar
  13. S. Sriramula, J. P. Cardinale, E. Lazartigues, and J. Francis, “ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension,” Cardiovascular Research, vol. 92, no. 3, pp. 401–408, 2011. View at Publisher · View at Google Scholar
  14. T. M. Gwathmey, K. D. Pendergrass, S. D. Reid, J. C. Rose, D. I. Diz, and M. C. Chappell, “Angiotensin-(1–7)-angiotensin-converting enzyme 2 attenuates reactive oxygen species formation to angiotensin ii within the cell nucleus,” Hypertension, vol. 55, no. 1, pp. 166–171, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. M. C. Chappell, “Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1–7)-Mas receptor axis: more than regulation of blood pressure?” Hypertension, vol. 50, no. 4, pp. 596–599, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. R. A. S. Santos, A. J. Ferreira, and A. C. Simões e Silva, “Recent advances in the angiotensin-converting enzyme 2-angiotensin(1–7)-Mas axis,” Experimental Physiology, vol. 93, no. 5, pp. 519–527, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. J. J. Mullins, J. Peters, and D. Ganten, “Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene,” Nature, vol. 344, no. 6266, pp. 541–544, 1990. View at Publisher · View at Google Scholar · View at Scopus
  18. J. J. Mullins and D. Ganten, “Transgenic animals: new approaches to hypertension research,” Journal of Hypertension, vol. 8, no. 7, pp. S35–S37, 1990. View at Scopus
  19. M. Schinke, M. Bohm, G. Bricca, A. Lippoldt, M. Bader, and D. Ganten, “Antisense RNA expression modulates angiotensinogen synthesis in cell culture and in the brain of transgenic rats,” Hypertension, vol. 26, no. 3, pp. 547–546, 1995.
  20. M. Schinke, O. Baltatu, M. Böhm et al., “Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 7, pp. 3975–3980, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. A. C. Arnold, A. Sakima, S. O. Kasper, S. Vinsant, M. A. Garcia-Espinosa, and D. I. Diz, “The brain renin-angiotensin system and cardiovascular responses to stress: insights from transgenic rats with low brain angiotensinogen,” Journal of Applied Physiology, vol. 113, no. 12, pp. 1929–1936, 2012. View at Publisher · View at Google Scholar
  22. A. Sakima, D. B. Averill, S. O. Kasper et al., “Baroreceptor reflex regulation in anesthetized transgenic rats with low glia-derived angiotensinogen,” American Journal of Physiology, vol. 292, no. 3, pp. H1412–H1419, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. A. C. Arnold, M. Nautiyal, and D. I. Diz, “Protein phosphatase 1b in the solitary tract nucleus is necessary for normal baroreflex function,” Journal of Cardiovascular Pharmacology, vol. 59, no. 5, pp. 472–478, 2012. View at Publisher · View at Google Scholar
  24. K. K. Griendling and M. Ushio-Fukai, “Reactive oxygen species as mediators of angiotensin II signaling,” Regulatory Peptides, vol. 91, no. 1–3, pp. 21–27, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. S. R. Datla and K. K. Griendling, “Reactive oxygen species, NADPH oxidases, and hypertension,” Hypertension, vol. 56, no. 3, pp. 325–330, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. M. C. Zimmerman, E. Lazartigues, J. A. Lang et al., “Superoxide mediates the actions of angiotensin II in the central nervous system,” Circulation Research, vol. 91, no. 11, pp. 1038–1045, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. M. C. Zimmerman, R. P. Dunlay, E. Lazartigues et al., “Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain,” Circulation Research, vol. 95, no. 5, pp. 532–539, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Wang, J. Anrather, J. Huang, R. C. Speth, V. M. Pickel, and C. Iadecola, “NADPH oxidase contributes to angiotensin II signaling in the nucleus tractus solitarius,” Journal of Neuroscience, vol. 24, no. 24, pp. 5516–5524, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. E. M. V. de Cavanagh, F. Inserra, M. Ferder, and L. Ferder, “From mitochondria to disease: role of the renin-angiotensin system,” American Journal of Nephrology, vol. 27, no. 6, pp. 545–553, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. S. I. Dikalov, W. Li, A. K. Doughan, R. R. Blanco, and A. M. Zafari, “Mitochondrial reactive oxygen species and calcium uptake regulate activation of phagocytic NADPH oxidase,” American Journal of Physiology, vol. 302, no. 10, pp. R1134–R1142, 2012.
  31. A. K. Doughan, D. G. Harrison, and S. I. Dikalov, “Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction,” Circulation Research, vol. 102, no. 4, pp. 488–496, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Kimura, G. X. Zhang, A. Nishiyama et al., “Mitochondria-derived reactive oxygen species and vascular MAP kinases: comparison of angiotensin II and diazoxide,” Hypertension, vol. 45, no. 3, pp. 438–444, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. A. E. Dikalova, A. T. Bikineyeva, K. Budzyn et al., “Therapeutic targeting of mitochondrial superoxide in hypertension,” Circulation Research, vol. 107, no. 1, pp. 106–116, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. S. I. Dikalov and R. R. Nazarewicz, “Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease,” Antioxidants and Redox Signaling. In press. View at Publisher · View at Google Scholar
  35. K. Block, Y. Gorin, and H. E. Abboud, “Subcellular localization of Nox4 and regulation in diabetes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 34, pp. 14385–14390, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. S. M. Kim, Y. G. Kim, K. H. Jeong et al., “Angiotensin II-induced mitochondrial Nox4 is a major endogenous source of oxidative stress in kidney tubular cells,” PLoS ONE, vol. 7, no. 7, Article ID e39739, 2012. View at Publisher · View at Google Scholar
  37. J. Kuroda, T. Ago, S. Matsushima, P. Zhai, M. D. Schneider, and J. Sadoshima, “NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 35, pp. 15565–15570, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. I. F. Benter, M. H. M. Yousif, G. S. Dhaunsi, J. Kaur, M. C. Chappell, and D. I. Diz, “Angiotensin-(1–7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats,” American Journal of Nephrology, vol. 28, no. 1, pp. 25–33, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. G. S. Dhaunsi, M. H. M. Yousif, S. Akhtar, M. C. Chappell, D. I. Diz, and I. F. Benter, “Angiotensin-(1–7) prevents diabetes-induced attenuation in PPAR-γ and catalase activities,” European Journal of Pharmacology, vol. 638, no. 1–3, pp. 108–114, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Nautiyal, P. V. Katakam, D. W. Busija et al., “Differences in oxidative stress status and expression of MKP-1 in dorsal medulla of transgenic rats with altered brain renin-angiotensin system,” American Journal of Physiology, vol. 303, no. 8, pp. R799–R806, 2012.
  41. M. H. Yousif, G. S. Dhaunsi, B. M. Makki, B. A. Qabazard, S. Akhtar, and I. F. Benter, “Characterization of Angiotensin-(1–7) effects on the cardiovascular system in an experimental model of type-1 diabetes,” Pharmacological Research, vol. 66, no. 3, pp. 269–275, 2012. View at Publisher · View at Google Scholar
  42. Y. Hirooka, “Role of reactive oxygen species in brainstem in neural mechanisms of hypertension,” Autonomic Neuroscience: Basic and Clinical, vol. 142, no. 1-2, pp. 20–24, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. J. R. Peterson, R. V. Sharma, and R. L. Davisson, “Reactive oxygen species in the neuropathogenesis of hypertension,” Current Hypertension Reports, vol. 8, no. 3, pp. 232–241, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. S. H. H. Chan, K. L. H. Wu, A. Y. W. Chang, M. H. Tai, and J. Y. H. Chan, “Oxidative impairment of mitochondrial electron transport chain complexes in rostral ventrolateral medulla contributes to neurogenic hypertension,” Hypertension, vol. 53, no. 2, pp. 217–227, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Nozoe, Y. Hirooka, Y. Koga et al., “Mitochondria-derived reactive oxygen species mediate sympathoexcitation induced by angiotensin II in the rostral ventrolateral medulla,” Journal of Hypertension, vol. 26, no. 11, pp. 2176–2184, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Y. Jun, J. Zubcevic, Y. Qi, and M. K. Raizada, “Scavenging of mitochondrial ros in the brain prevents neurogenic hypertension,” in Proceedings of the 25th International Symposium on Cerebral Blood Flow, Metabolism and Function, 2011.
  47. K. Ogawa, Y. Hirooka, K. Shinohara, T. Kishi, and K. Sunagawa, “Inhibition of oxidative stress in rostral ventrolateral medulla improves impaired baroreflex sensitivity in stroke-prone spontaneously hypertensive rats,” International Heart Journal, vol. 53, no. 3, pp. 193–198, 2012. View at Publisher · View at Google Scholar
  48. V. A. Braga, E. Colombari, and M. G. Jovita, “Angiotensin II-derived reactive oxygen species underpinning the processing of the cardiovascular reflexes in the medulla oblongata,” Neuroscience Bulletin, vol. 27, no. 4, pp. 269–274, 2011. View at Publisher · View at Google Scholar
  49. M. Nautiyal, H. A. Shaltout, D. C. de Lima, N. K. do, M. C. Chappell, and D. I. Diz, “Central angiotensin-(1–7) improves vagal function independent of blood pressure in hypertensive (mRen2)27 rats,” Hypertension, vol. 60, no. 5, pp. 1257–1265, 2012. View at Publisher · View at Google Scholar
  50. J. D. Malhotra and R. J. Kaufman, “ER stress and its functional link to mitochondria: role in cell survival and death,” Cold Spring Harbor Perspectives in Biology, vol. 3, no. 9, Article ID a004424, 2011.
  51. C. N. Young, X. Cao, M. R. Guruju et al., “ER stress in the brain subfornical organ mediates angiotensin-dependent hypertension.,” Journal of Clinical Investigation, vol. 122, no. 11, pp. 3960–3964, 2012. View at Publisher · View at Google Scholar
  52. S. H. H. Chan, K. S. Hsu, C. C. Huang, L. L. Wang, C. C. Ou, and J. Y. H. Chan, “NADPH oxidase-derived superoxide anion mediates angiotensin II-induced pressor effect via activation of p38 mitogen-activated protein kinase in the rostral ventrolateral medulla,” Circulation Research, vol. 97, no. 8, pp. 772–780, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. S. H. H. Chan, L. L. Wang, H. L. Tseng, and J. Y. H. Chan, “Upregulation of AT1 receptor gene on activation of protein kinase Cβ/nicotinamide adenine dinucleotide diphosphate oxidase/ERK1/2/c-fos signaling cascade mediates long-term pressor effect of angiotensin II in rostral ventrolateral medulla,” Journal of Hypertension, vol. 25, no. 9, pp. 1845–1861, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. T. Kishi, Y. Hirooka, S. Konno, K. Ogawa, and K. Sunagawa, “Angiotensin II type 1 receptor-activated caspase-3 through ras/mitogen-activated protein kinase/extracellular signal-regulated kinase in the rostral ventrolateral medulla is involved in sympathoexcitation in stroke-prone spontaneously hypertensive rats,” Hypertension, vol. 55, no. 2, pp. 291–297, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. E. M. Logan, A. A. Aileru, H. A. Shaltout, D. B. Averill, and D. I. Diz, “The functional role of PI3K in maintenance of blood pressure and baroreflex suppression in (mRen2)27 and mRen2.Lewis rat,” Journal of Cardiovascular Pharmacology, vol. 58, no. 4, pp. 367–373, 2011. View at Publisher · View at Google Scholar
  56. M. Soulsby and A. M. Bennett, “Physiological signaling specificity by protein tyrosine phosphatases,” Physiology, vol. 24, no. 5, pp. 281–289, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. R. J. R. Flach and A. M. Bennett, “Mitogen-activated protein kinase phosphatase-1—a potential therapeutic target in metabolic disease,” Expert Opinion on Therapeutic Targets, vol. 14, no. 12, pp. 1323–1332, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. R. C. Tsou and K. K. Bence, “The genetics of PTPN1 and obesity: insights from mouse models of tissue-specific PTP1B deficiency,” Journal of Obesity, vol. 2012, Article ID 926857, 8 pages, 2012. View at Publisher · View at Google Scholar
  59. M. Elchebly, P. Payette, E. Michaliszyn et al., “Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene,” Science, vol. 283, no. 5407, pp. 1544–1548, 1999. View at Publisher · View at Google Scholar · View at Scopus
  60. J. J. Wu, R. J. Roth, E. J. Anderson et al., “Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity,” Cell Metabolism, vol. 4, no. 1, pp. 61–73, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. R. J. Roth, A. M. Le, L. Zhang et al., “MAPK phosphatase-1 facilitates the loss of oxidative myofibers associated with obesity in mice,” Journal of Clinical Investigation, vol. 119, no. 12, pp. 3817–3829, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. S. O. Kasper, C. S. Carter, C. M. Ferrario et al., “Growth, metabolism, and blood pressure disturbances during aging in transgenic rats with altered brain renin-angiotensin systems,” Physiological Genomics, vol. 23, no. 3, pp. 311–317, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. S. O. Kasper, C. M. Ferrario, D. Ganten, and D. I. Diz, “Rats with low brain angiotensinogen do not exhibit insulin resistance during early aging,” Endocrine, vol. 30, no. 2, pp. 167–174, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. D. I. Diz, S. O. Kasper, A. Sakima, and C. M. Ferrario, “Aging and the brain renin-angiotensin system: insights from studies in transgenic rats,” Cleveland Clinic Journal of Medicine, vol. 74, supplement 1, pp. S95–S98, 2007. View at Scopus
  65. R. Bergeron, J. M. Ren, K. S. Cadman et al., “Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis,” American Journal of Physiology, vol. 281, no. 6, pp. E1340–E1346, 2001. View at Scopus
  66. L. H. Young, J. Li, S. J. Baron, and R. R. Russell, “AMP-activated protein kinase: a key stress signaling pathway in the heart,” Trends in Cardiovascular Medicine, vol. 15, no. 3, pp. 110–118, 2005. View at Publisher · View at Google Scholar · View at Scopus